Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin
- PMID: 1700695
- PMCID: PMC1131779
- DOI: 10.1042/bj2700639
Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin
Abstract
Recombinant eglin c is a potent reversible inhibitor of human pancreatic elastase. At pH 7.4 and 25 degrees C, kass. = 7.3 x 10(5) M-1.s-1, kdiss. = 2.7 x 10(-4) s-1 and Ki = 3.7 x 10(-10) M. Stopped-flow kinetic indicate that the formation of the stable enzyme-inhibitor complex is not preceded by a fast pre-equilibrium complex or that the latter has a dissociation constant greater than 0.3 microM. The elastase-eglin c complex is much less stable at pH 5.0 and 25 degrees C, where kdiss. = 1.1 x 10(-2) s-1 and Ki = 7.3 x 10(-8) M. At pH 7.4 the activation energy for kass. is 43.9 kJ.mol-1 (10.5 kcal.mol-1). The kass. increases between pH 5.0 and 8.0 and remains essentially constant up to pH 9.0. This pH-dependence could not be described by a simple ionization curve. Both alpha 2-macroglobulin and alpha 1-proteinase inhibitor are able to dissociate the elastase-eglin c complex, as evidenced by measurement of the enzymic activity of alpha 2-macroglobulin-bound elastase or by polyacrylamide-gel electrophoresis of mixtures of alpha 1-proteinase inhibitor and elastase-eglin c complex. The rough estimate of kdiss. obtained with the alpha 2-macroglobulin dissociation experiment (1.6 x 10(-4) s-1) was of the same order of magnitude as the constant measured with the progress curve method. Eglin c strongly inhibits the solubilization of human aorta elastin by human pancreatic elastase. The extent of inhibition is the same whether elastase is added to a suspension of elastin and eglin c or whether elastase is preincubated with elastin for 3 min before addition of eglin c. However, the efficiency of the inhibitor sharply decreases if elastase is reacted with elastin for more prolonged periods.
Similar articles
-
Kinetics of the interaction of chymotrypsin with eglin c.Biochem J. 1991 Nov 15;280 ( Pt 1)(Pt 1):27-32. doi: 10.1042/bj2800027. Biochem J. 1991. PMID: 1741752 Free PMC article.
-
Kinetics of the inhibition of free and elastin-bound human pancreatic elastase by alpha 1-proteinase inhibitor and alpha 2-macroglobulin.Biochim Biophys Acta. 1989 Feb 23;994(3):285-8. doi: 10.1016/0167-4838(89)90306-3. Biochim Biophys Acta. 1989. PMID: 2465784
-
Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G.Biol Chem Hoppe Seyler. 1987 Apr;368(4):299-308. doi: 10.1515/bchm3.1987.368.1.299. Biol Chem Hoppe Seyler. 1987. PMID: 3649242
-
[Human leukocyte elastase].Pathol Biol (Paris). 1988 Nov;36(9):1108-11. Pathol Biol (Paris). 1988. PMID: 3065702 Review. French.
-
Elastases and elastin degradation.J Invest Dermatol. 1982 Jul;79 Suppl 1:154s-159s. doi: 10.1111/1523-1747.ep12546056. J Invest Dermatol. 1982. PMID: 7045242 Review.
Cited by
-
Kinetics of the interaction of chymotrypsin with eglin c.Biochem J. 1991 Nov 15;280 ( Pt 1)(Pt 1):27-32. doi: 10.1042/bj2800027. Biochem J. 1991. PMID: 1741752 Free PMC article.
-
Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin.Biochem J. 1996 Jan 15;313 ( Pt 2)(Pt 2):555-60. doi: 10.1042/bj3130555. Biochem J. 1996. PMID: 8573092 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources